Daniel Gritters, NP

NPI: 1205249414
Total Payments
$500.43
2024 Payments
$145.09
Companies
8
Transactions
17
Medicare Patients
719
Medicare Billing
$66,853

Payment Breakdown by Category

Food & Beverage$500.43 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $500.43 17 100.0%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $154.64 7 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $107.09 1 $0 (2023)
AstraZeneca Pharmaceuticals LP $51.59 3 $0 (2024)
Genentech USA, Inc. $47.33 2 $0 (2023)
Regeneron Healthcare Solutions, Inc. $46.44 1 $0 (2021)
Ethicon Inc. $43.45 1 $0 (2024)
VERTEX PHARMACEUTICALS INCORPORATED $25.85 1 $0 (2021)
Actelion Pharmaceuticals US, Inc. $24.04 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $145.09 6 GENZYME CORPORATION ($53.31)
2023 $192.59 5 Boehringer Ingelheim Pharmaceuticals, Inc. ($107.09)
2022 $75.01 3 GENZYME CORPORATION ($61.44)
2021 $87.74 3 Regeneron Healthcare Solutions, Inc. ($46.44)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/20/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $24.04 General
Category: Cardiology
12/20/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $13.89 General
Category: Immunology
12/12/2024 Ethicon Inc. Monarch Platform (Device) Food and Beverage In-kind items and services $43.45 General
Category: Endo-Mechanical
12/06/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $24.29 General
Category: Respiratory
07/25/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $16.02 General
Category: Immunology
05/08/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $23.40 General
Category: Immunology
11/30/2023 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $27.42 General
Category: Immunology
07/20/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $24.44 General
06/29/2023 Genentech USA, Inc. Tecentriq (Biological) Food and Beverage In-kind items and services $19.91 General
Category: BioOncology
05/30/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.73 General
Category: Respiratory
03/22/2023 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $107.09 General
12/01/2022 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $13.57 General
Category: Respiratory
05/10/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $39.53 General
Category: Immunology
04/14/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.91 General
Category: Immunology
12/15/2021 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Food and Beverage In-kind items and services $25.85 General
Category: CYSTIC FIBROSIS
10/21/2021 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $46.44 General
Category: INFLAMMATION AND IMMUNOLOGY
08/25/2021 GENZYME CORPORATION Food and Beverage In-kind items and services $15.45 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 172 230 $47,514 $15,785
2022 3 147 194 $44,841 $15,116
2021 7 240 317 $62,369 $21,783
2020 4 160 197 $43,168 $14,169
Total Patients
719
Total Services
938
Medicare Billing
$66,853
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 39 50 $10,850 $3,815 35.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 32 33 $9,602 $3,460 36.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 36 42 $9,247 $3,122 33.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 23 24 $9,840 $2,710 27.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 34 $5,202 $1,721 33.1%
G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th Facility 2023 16 47 $2,773 $956.71 34.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 54 91 $19,383 $6,214 32.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 61 67 $14,874 $4,994 33.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 32 36 $10,584 $3,907 36.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 68 128 $27,012 $8,870 32.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 59 66 $14,528 $5,483 37.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 28 31 $9,044 $3,743 41.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 27 29 $4,308 $1,398 32.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 22 23 $3,457 $1,214 35.1%
94729 Measurement of lung diffusing capacity Office 2021 17 19 $2,030 $689.58 34.0%
94010 Measurement and graphic recording of total and timed exhaled air capacity Office 2021 19 21 $1,990 $384.40 19.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 61 92 $19,080 $6,561 34.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 51 55 $11,898 $3,635 30.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 34 35 $10,000 $3,232 32.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 14 15 $2,190 $740.85 33.8%

About Daniel Gritters, NP

Daniel Gritters, NP is a Registered Nurse healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205249414.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Gritters, NP has received a total of $500.43 in payments from pharmaceutical and medical device companies, with $145.09 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($500.43).

As a Medicare-enrolled provider, Gritters has provided services to 719 Medicare beneficiaries, totaling 938 services with total Medicare billing of $66,853. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Family
  • Location Grand Rapids, MI
  • Active Since 06/05/2014
  • Last Updated 03/04/2021
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1205249414

Products in Payments

  • DUPIXENT (Biological) $161.19
  • Monarch Platform (Device) $43.45
  • Xolair (Biological) $27.42
  • TRIKAFTA (Drug) $25.85
  • FASENRA (Biological) $24.29
  • OPSUMIT (Drug) $24.04
  • Tecentriq (Biological) $19.91
  • BREZTRI (Drug) $13.73
  • TEZSPIRE (Biological) $13.57

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Grand Rapids